UK Penny Stocks With Market Caps Over £80M To Watch

The UK market has recently experienced some turbulence, with the FTSE 100 index closing lower due to weak trade data from China, highlighting ongoing global economic challenges. Despite these broader market fluctuations, certain investment opportunities remain appealing, particularly in the realm of penny stocks. While the term "penny stocks" might seem outdated, these investments often involve smaller or newer companies that can offer significant growth potential when supported by strong financial health and solid fundamentals.

Let's uncover some gems from our specialized screener.

Amcomri Group (AIM:AMCO)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Amcomri Group plc operates in the engineering and industrial manufacturing sectors within the United Kingdom, with a market capitalization of £89.25 million.

Operations: The company's revenue is derived from two main segments: B2B Manufacturing, which contributes £33.76 million, and Embedded Engineering, generating £37.18 million.

Market Cap: £89.25M

Amcomri Group plc, with a market capitalization of £89.25 million, operates within the engineering and industrial manufacturing sectors in the UK. The company has demonstrated robust earnings growth, with a 187.4% increase over the past year and forecasts suggesting continued growth at 26.41% annually. Amcomri's financial health is supported by short-term assets exceeding liabilities and satisfactory debt levels with well-covered interest payments. Recent corporate guidance indicates significant revenue and profit increases for H1 2026 compared to H1 2025, showcasing strong operational performance despite low return on equity and an inexperienced board of directors.

• Click to explore a detailed breakdown of our findings in Amcomri Group's financial health report.
• Explore Amcomri Group's analyst forecasts in our growth report.

Ten Lifestyle Group (AIM:TENG)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Ten Lifestyle Group Plc provides concierge services to private banks, premium financial services, and high-net-worth individuals across various regions including Europe, Asia-Pacific, the Middle East, Africa, and the Americas with a market cap of £93.68 million.

Operations: The company has not reported any specific revenue segments.

Market Cap: £93.68M

Ten Lifestyle Group, with a market cap of £93.68 million, has shown profitability over the past five years but faced negative earnings growth recently. The company remains debt-free, with short-term assets exceeding both long and short-term liabilities. Recent developments include securing a multi-year contract with a major client for concierge services in the Americas and partnering with AEG Presents to enhance event access for members. Despite stable weekly volatility and seasoned management, Ten's profit margins have declined from last year, and its return on equity is low at 5.1%. The stock trades below estimated fair value by 31.3%.

• Unlock comprehensive insights into our analysis of Ten Lifestyle Group stock in this financial health report.
• Understand Ten Lifestyle Group's earnings outlook by examining our growth report.

Zotefoams (LSE:ZTF)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Zotefoams plc, with a market cap of £221.17 million, manufactures, distributes, and sells foam materials across Europe, the Middle East, Africa, North America, and Asia.

Operations: The company's revenue is primarily derived from the EMEA region at £136.19 million, followed by North America at £34.21 million, Asia at £5.70 million, and Mucell Extrusion LLC contributing £0.20 million.

Market Cap: £221.17M

Zotefoams plc, with a market cap of £221.17 million, has demonstrated substantial earnings growth over the past year at 3335.8%, far outpacing the chemicals industry average. The company's revenue is primarily driven by its EMEA operations (£136.19 million), with strong contributions from North America and Asia as well. Despite a relatively new management team, Zotefoams maintains high-quality earnings and robust financial health, evidenced by its ability to cover interest payments 13 times over with EBIT and satisfactory net debt to equity ratio of 28.2%. The stock trades significantly below estimated fair value by 75.4%.

• Click here and access our complete financial health analysis report to understand the dynamics of Zotefoams.
• Gain insights into Zotefoams' outlook and expected performance with our report on the company's earnings estimates.

Next Steps

• Navigate through the entire inventory of 276 UK Penny Stocks here.
• Curious About Other Options? AI is about to change healthcare. These 134 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com